FARMINGTON, CT & PHILADELPHIA, PA — Torigen Pharmaceuticals is making strides in veterinary medicine by employing Proscia’s Concentriq® software to enhance its Specialty Pathology Service. This advanced enterprise pathology platform allows Torigen’s team to deliver rapid and precise diagnoses, enabling veterinarians to make informed care decisions for pets with potentially life-threatening conditions like cancer.
Torigen pathologists leverage Concentriq to analyze data-rich images, offering comprehensive profiles of diseases that inform both treatment strategies and the development of personalized vaccines. The platform enables efficient workflows, ensuring diagnostic results within an average of three to five days, which allows pet owners and veterinarians to initiate treatment plans sooner.
“Concentriq made our vision for Torigen Specialty Pathology a reality,” said Ashley Kalinauskas, CEO and Co-Founder of Torigen Pharmaceuticals. “We are now able to help veterinary practices of all sizes create hope for pets and their families by building the bridge between diagnostics and personalized immunotherapies, pushing the limits of animal medicine.”
Founded to bring personalized cancer vaccines to the veterinary market, Torigen has already demonstrated the effectiveness of its innovative therapies. Preliminary research has shown that dogs with metastatic hemangiosarcoma receiving Torigen’s targeted immunotherapy or maximum tolerated dose chemotherapy experienced a 3.5x increase in overall survival compared to surgery alone.
Furthermore, the adoption of Proscia’s Concentriq marks the start of Torigen’s efforts to establish a data foundation for developing AI models. These AI-driven advancements aim to optimize immunotherapy recommendations, pushing precision veterinary medicine even further.
“The healthcare community should take note of Torigen,” said David West, CEO of Proscia. “Realizing the promise of precision medicine depends on matching patients with the right treatments, and Torigen is addressing this full pathway. We are thrilled to play a part in its journey and in the lives of the pets, families, and veterinarians it serves.”
Torigen Pharmaceuticals remains committed to advancing veterinary care, blending cutting-edge technology with personalized medicine to redefine possibilities in animal healthcare. The company’s focus on precision diagnostics and tailored immunotherapies promises new hope for pets and their families while setting a high standard for innovation in the industry.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.